March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents in all diseased arteries was found to be as safe and effective at one year of follow-up as staged treatment, according to findings from the first large, randomized trial to address this question that is being presented at the American College of Cardiology’s Annual Scientific Session Together With the

March 5, 2023 — In the largest randomized trial conducted to compare minimally invasive and conventional cardiac surgical techniques for repairing a poorly functioning mitral valve, improvements in physical activity, as well as surgical outcomes and quality of life, were similar in both groups of patients at 12 weeks post-surgery.

March 4, 2023 — The impact of statin use to prevent heart damage during a cancer patient’s chemotherapy was in focus during a late-breaking scientific session, on the STOP-CA Trial, presented at the American College of Cardiology’s Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, being held March 4-6 in

March 4, 2023 - Lexicon Pharmaceuticals, Inc.  announced new analyses of results from the SOLOIST-WHF Phase 3 outcomes study of its investigational product sotagliflozin presented at the American College of Cardiology’s 72nd Ann

March 4, 2023 — The cholesterol-lowering drug bempedoic acid was found to reduce the combined rate of major adverse cardiovascular events by 13%, meeting its primary endpoint in a large study of patients with high cholesterol who were unable to tolerate statins, according to research reported on during the American College of Cardiology’s Annual Scientific Session Together with the World Congress of Cardio